By proceeding, you agree to our Terms of Use and Privacy Policy.
Teresa Wegesser is a Principal Scientist at Amgen Inc. working as a nonclinical Project Team Representative on various cross-functional small and large molecule drug development teams since 2015.
Talks About #nitrosamines #drugdevelopment #biotechnology
Preferred Locations #NorthAmerica
The formation of nitrosamines as well as other mutagenic impurities in drug substances and drug products maycompromise their safety, quality, and clinical outcomes.